User:Ajeffs: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
Line 25: Line 25:
===Peer-reviewed===
===Peer-reviewed===
<biblio>
<biblio>
#Jenkins-2008 Zandra A. Jenkins, Margriet van Kogelenberg, Tim Morgan, Aaron Jeffs, Ryuji Fukuzawa3 Esther Pearl, Christina Thaller, Anne V. Hing, Mary E. Porteous, Sixto Garcia-Miñaur, Axel Bohring, Didier Lacombe, Fiona Stewart, Torunn Fiskerstrand, Laurence Bindoff, Siren Berland, Lesley C. Adès, Michel Tchan, Albert David, Louise C. Wilson, Raoul CM Hennekam, Dian Donnai, Sahar Mansour, Valérie Cormier-Daire, Stephen P. Robertson (2008). ''Germline mutations in the tumor suppressor WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis''. Nature Genetics, in press.
#Jenkins-2008 Zandra A. Jenkins, Margriet van Kogelenberg, Tim Morgan, Aaron Jeffs, Ryuji Fukuzawa, Esther Pearl, Christina Thaller, Anne V. Hing, Mary E. Porteous, Sixto Garcia-Miñaur, Axel Bohring, Didier Lacombe, Fiona Stewart, Torunn Fiskerstrand, Laurence Bindoff, Siren Berland, Lesley C. Adès, Michel Tchan, Albert David, Louise C. Wilson, Raoul CM Hennekam, Dian Donnai, Sahar Mansour, Valérie Cormier-Daire, Stephen P. Robertson (2008). ''Germline mutations in the tumor suppressor WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis''. Nature Genetics, in press.
#Dziarmaga-2006 pmid=16735463
#Dziarmaga-2006 pmid=16735463
#Futschik-2002 M. Futschik, A.Jeffs, S.Pattison, N.Kasabov, M.Sullivan, A.Merrie, A.Reeve (2002). ''Gene expression profiling of metastatic and non-metastatic colorectal cancer cell-lines''. Genome Letters 1(1):26-34.
#Futschik-2002 M. Futschik, A.Jeffs, S.Pattison, N.Kasabov, M.Sullivan, A.Merrie, A.Reeve (2002). ''Gene expression profiling of metastatic and non-metastatic colorectal cancer cell-lines''. Genome Letters 1(1):26-34.

Revision as of 23:46, 29 October 2008

Back to Eccles Lab | Notebook <html><a href="/wiki/User:Ajeffs/Notebook"><img src="/images/9/94/Report.png" border="0" /></a></html>


Aaron Jeffs

Developmental Genetics Group
Department of Pathology
Dunedin School of Medicine
University of Otago
Dunedin
New Zealand

aaron.jeffs at otago.ac.nz

Research Interests

  • Cancer genetics
  • Oncogenomics

Education

  • MSc Hons (Canterbury)
  • PhD (Otago)

Publications

Peer-reviewed

  1. Zandra A. Jenkins, Margriet van Kogelenberg, Tim Morgan, Aaron Jeffs, Ryuji Fukuzawa, Esther Pearl, Christina Thaller, Anne V. Hing, Mary E. Porteous, Sixto Garcia-Miñaur, Axel Bohring, Didier Lacombe, Fiona Stewart, Torunn Fiskerstrand, Laurence Bindoff, Siren Berland, Lesley C. Adès, Michel Tchan, Albert David, Louise C. Wilson, Raoul CM Hennekam, Dian Donnai, Sahar Mansour, Valérie Cormier-Daire, Stephen P. Robertson (2008). Germline mutations in the tumor suppressor WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis. Nature Genetics, in press.

    [Jenkins-2008]
  2. Dziarmaga A, Hueber PA, Iglesias D, Hache N, Jeffs A, Gendron N, Mackenzie A, Eccles M, and Goodyer P. Neuronal apoptosis inhibitory protein is expressed in developing kidney and is regulated by PAX2. Am J Physiol Renal Physiol. 2006 Oct;291(4):F913-20. DOI:10.1152/ajprenal.00004.2006 | PubMed ID:16735463 | HubMed [Dziarmaga-2006]
  3. M. Futschik, A.Jeffs, S.Pattison, N.Kasabov, M.Sullivan, A.Merrie, A.Reeve (2002). Gene expression profiling of metastatic and non-metastatic colorectal cancer cell-lines. Genome Letters 1(1):26-34.

    [Futschik-2002]
  4. Jeffs AR, Wells E, and Morris CM. Nonrandom distribution of interspersed repeat elements in the BCR and ABL1 genes and its relation to breakpoint cluster regions. Genes Chromosomes Cancer. 2001 Oct;32(2):144-54. DOI:10.1002/gcc.1176 | PubMed ID:11550282 | HubMed [Jeffs-2001]
  5. Benjes SM, Millow LJ, Jeffs AR, Sowerby SJ, Reeve AE, and Morris CM. 3' BCR recombines with IGL locus in BCR-ABL-positive philadelphia-negative chronic myeloid leukemia. Genes Chromosomes Cancer. 1999 Dec;26(4):366-71. PubMed ID:10534772 | HubMed [Benjes-1999]
  6. Jeffs AR, Benjes SM, Smith TL, Sowerby SJ, and Morris CM. The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia. Hum Mol Genet. 1998 May;7(5):767-76. DOI:10.1093/hmg/7.5.767 | PubMed ID:9536079 | HubMed [Jeffs-1998]
  7. Morris C, Jeffs A, Smith T, McDonald M, Board P, Kennedy M, and Fitzgerald P. BCR gene recombines with genomically distinct sites on band 11Q13 in complex BCR-ABL translocations of chronic myeloid leukemia. Oncogene. 1996 Feb 1;12(3):677-85. PubMed ID:8637725 | HubMed [Morris-1996]

All Medline abstracts: PubMed | HubMed

Non-peer-reviewed

  1. Robson, Ewan, Jeffs, Aaron, and Eccles, Michael. Off-target response to decoy oligodeoxynucleotide treatment. Available from Nature Precedings <http://hdl.handle.net/10101/npre.2008.2281.1> (2008)

    [Robson-2008]